Home
This site is intended for healthcare professionals
Advertisement

Respiratory Paediatric Presentations - Dr Dara O'Donoghue

180 views
Share
Advertisement
Advertisement
 
 
 

Related content

Similar communities

View all

Similar events and on demand videos

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

Respiratory Paediatrics Dara O’Donoghue RBHSC/QUBRespiratory Paediatrics • Bronchiolitis • Croup • Asthma • Chronic Productive cough • Cystic Fibrosis • Obstructive sleep apneaBronchiolitisReferral • Apnoea • RR>60/min • Looks seriously unwell • Severe respiratory distress • Reduced oral fluid intake (50-75% of usual) - Grunting, marked chest • Clinical dehydration recession or RR>70/min • Persistent oxygen saturation <925 in • Central cyanosis room airCroupCroup • Treatment 0.15 mg/kg of dexamethasone • Budesonide nebuliser • Adrenaline nebuliser 2.5-5ml 1:1000 • Differential Diagnosis - Foreign body - Anaphylaxis - Tracheitis - Epiglottitishttps://what0-18.nhs.ukAsthmaERS Clinical Practice Guidelines for the diagnosis of asthma in children aged 5-16 years April 2021 • Asthma is a disease that includes the symptoms of wheeze, cough and breathing difficulty together with reversible airways obstruction, airway inflammation and bronchial hyperresponsiveness.Asthma therapyNational Review of Asthma Related Deaths • 1 Uk wide investigation of asthma deaths • Multiprofessional panel • 1 Feb 2012-31 Jan 2013 • 195 deaths • 14% <19 years The National Review of Asthma Deaths in the UK • Prescribing data in the year preceding death Prescriptions for ICS and/or ICS-combination inhalers • 14% of patients had not been prescribed an ICS inhaler Prescriptions for SABA inhalers (n=165) • 4% (6 patients) prescribed >50 inhalers Most patients were undertreated (n=128) 38% of patients had been issued <4 preventer inhalerss • Royal College of Physicians. Why asthma still kills: The National Review of Asthma Deaths (NRAD) 2014. AvailableBTS/SIGN 16Intervention – reminder electronic messages to collect preventer refillsCompliance • Repeat prescriptions • Smarthalers • Direct Observed therapy- schools • Remote direct observed therapy 18 Use of de • RBHSC uses dexamethasone 0.3 mg stat for acute asthma attacks • However no evidence that one has superior efficacy 1 1 • Dexamethsone is better tolerated ( less vomiting) • Dexamethosne is difficult to store in primary care children: a meta-analysis. Pediatrics. 2014 Mar;133(3):493-9ons inChronic Productive CoughChronic cough • Cough lasting > 4 weeks • Dry or productiveHistory • 4 ½ year old girl • Problematic cough for 1 year • Other noises? No – no wheeze or stridor • Audible loose cough throughout the consultation • Treatments tried • Clenil modulite and montelukast for 1 month • No improvement. Stopped and no deterioration • No oral steroids • Antibiotics x2 courses – no improvementPossible Diagnosis • Asthma – why not? • No wheeze • No response to treatment • Audible loose productive coughInvestigations • Spirometry normal • FeNO = 7ppbPossible Diagnosis • Asthma – why not? • No wheeze • No response to treatment • Audible loose productive cough • Diagnosis: Persistent bacterial bronchitis • Treatment: 4 week course Augmentin Duo • Review: excellent response!Persistent bacterial bronchitis • Wet cough in the absence of other diagnoses responds to antibiotic and recurs • Often treated with asthma therapy • Sputum/BAL • Haemophilus inf and Moraxella catarrhalis common • CXR –patchy/ bronchial wall thickeningSlides re PBBPersistent bacterial bronchitis • 2 -4 week course of antibiotics – 50% resolution • 15% will require 6 or more courses of antiobiotics • Strong association with large airway malacia • Can co-exist with asthma • Recurs- referPersistent bacterial bronchitis • ? Pre- bronchiectatic condition • Immune profile • Sweat test • Flexible bronchoscopy • Nasal Nitric Oxide- Primary Ciliary Dyskinesia • CT = ? bronchiectasisCystic Fibrosis Personalised medicine in CF • IVACAFTOR (KALYDECO) acts on transmembrane conductance regulator (CFTR) • Patients > 6 years old • At least 1 G551D mutation in the CFTR gene • LUMACAFTOR/IVACAFTOR ( ORKAMBI) • Patients >2 years • 2 copies of delta F508 mutationObstructive Sleep ApneaOSA • Snoring and restlessness at night a cause of ‘backwardness and stupidity in children’ • First case series published 1982 1 Hill 1889. On some causes of backwardness in children BMJ 2 : 771-2Who is at risk? Normal airway Normal airway Small airway Normal T+A Large T+A Normal T+A Examples of the oxygen saturation trend graphs from overnight oximetry tests: from top to bottom, categories 1 to 4 Nixon, G. M. et al. Pediatrics 2004;113:e19-e25 Copyright ©2004 American Academy of PediatricsTreatment of OSA in children • Adenotonsillectomy • Weight loss • Positional therapy • Nasal steroids, decongestants/ antihistamines, Montelukast • Nasal CPAPRespiratory Paediatrics Dara O’Donoghue RBHSC/QUB